A potential new vaccine for COVID-19.  The European Commission approved the contract with Valneva

The agreement approved today allows for the vaccine to be adapted to new variants. Our wide range of vaccines will help us In the fight against Covid disease and its variants in Europe and abroad. The epidemic is not over yet. Anyone can get vaccinated – commented the President of the European Commission Ursula von der Leyen.

So far, the European Commission has concluded contracts with companies to produce vaccines in Europe AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNtech-Pfizer, CureVac, Moderna i Novavax.

Valniva is a French biotechnology company that is developing an inactivated virus vaccine, which is produced from live virus by chemical inhibition.

“It is a traditional vaccination technology that has been used for 60-70 years, with established methodology and a high level of safety. Most influenza vaccines and many primary vaccines use this technology. It is currently the only potential inactivated vaccine in clinical trials against Covid-19 in Europe”- The European Commission announced in a press release.


Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Record mega far. Discovered by a Polish-led team

MegaMaser It is an exceptionally powerful maser, i.e. a source of microwave…

The Earth’s troposphere is growing. Planes may get into trouble soon

An article with the results of the research was published in the…

This strange link was a waste fit. All it takes is an extra ingredient and we have a miracle

Researchers at Uppsala University in Sweden have developed the best possible version…

An amazing discovery about global warming. Scientists talk about a paradox – O2

Now it is clear that the pollution is good because Germany needs…